SARS-CoV-2 Spike receptor binding domain, RBD (348-357)- Lys(Biotin-LC)

Product Name: SARS-CoV-2 Spike receptor binding domain, RBD (348-357)- Lys(Biotin-LC)

Sequence One Letter Code: ASVYAWNRKR-K(Biotin-LC)-NH2

Sequence Three Letter Code: H-Ala-Ser-Val-Tyr-Ala-Trp-Asn-Arg-Lys-Arg-Lys(Biotin-LC)-NH2

Molecular Weight: 1717.1

Purity: ≥ 95% 

Storage Conditions: - 20 °C

Source / Species: SARS-CoV-2

Conjugation: Conjugated

Conjugation Type: Biotins

Code Nacres: NA.26

Application: SARS-CoV-2 Spike RBD (348–357)-Biotin-LC is a biotin-labeled synthetic peptide corresponding to residues 348–357 of the SARS-CoV-2 spike receptor-binding domain, based on RefSeq YP_009724390.1. The RBD mediates viral interaction with ACE2 and is an important target for immune recognition. The C-terminal Biotin-LC modification enables immobilization, affinity capture, and detection in binding assay formats. This peptide is useful for antibody screening, epitope mapping, receptor interaction studies, diagnostic assay development, and research focused on spike RBD-derived sequences involved in SARS-CoV-2 recognition.